Cogent Biosciences Financials - Benzinga

Cogent Biosciences Inc

COGTNASDAQ

Trade with Public

Trade with Public

$34.18

-1.10-3.12%

At close: Sep 9, 5:00 PM EST

$34.60

0.421.23%

After Hours: 6:41 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Cogent Biosciences Financials

Cogent Biosciences (COGT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Cogent Biosciences Q2 EPS $(0.52) Beats $(0.57) Estimate

Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.57) by 8.77 percent. This is a 1.89 percent increase over losses of $(0.53) per share from

Benzinga Newsdesk

PRO
Cogent Biosciences Q1 EPS $(0.53) Beats $(0.56) Estimate

Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.56) by 5.36 percent. This is a 1.92 percent decrease over losses of $(0.52) per share from

Benzinga Newsdesk

PRO
Cogent Biosciences Q4 EPS $(0.61) Misses $(0.53) Estimate

Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.53) by 15.97 percent. This is a 577.78 percent decrease over losses of $(0.09) per share

Benzinga Newsdesk

Gold Jumps Over 2%; Dole Shares Gain After Q3 Results

Avi Kapoor

S&P 500 Surges 1%; Tyson Foods Posts Upbeat Earnings

Avi Kapoor

PRO
Cogent Biosciences Q2 EPS $(0.53) Beats $(0.58) Estimate

Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.58) by 9.4 percent. This is a 10.17 percent increase over losses of $(0.59) per share from

Benzinga Newsdesk